Chemokine RANTES and IL-1β in mild therapeutic hypothermia-treated patients after out-of-hospital sudden cardiac arrest

Jakub Podolec; Aleksander Trąbka-Zawicki; Rafał Badacz; Mateusz Siedliński; Marek Tomala; Krzysztof Bartuś; Jacek Legutko; Tadeusz Przewłocki; Krzysztof Żmudka; Anna Kabłak-Ziembicka

doi:10.5114/aic.2019.83653

eISSN: 1897-4295
ISSN: 1734-9338

Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

1/2019
vol. 15

Send email

Copy url:

abstract:

Original paper

Chemokine RANTES and IL-1β in mild therapeutic hypothermia-treated patients after out-of-hospital sudden cardiac arrest

Jakub Podolec

,

Aleksander Trąbka-Zawicki

,

Rafał Badacz

,

Mateusz Siedliński

,

Marek Tomala

,

Krzysztof Bartuś

,

Jacek Legutko

,

Tadeusz Przewłocki

,

Krzysztof Żmudka

,

Anna Kabłak-Ziembicka

Adv Interv Cardiol 2019; 15, 1 (55): 98–106

DOI: https://doi.org/10.5114/aic.2019.83653

Online publish date: 2019/03/15

View full text Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Podolec J, Trąbka-Zawicki A, Badacz R, et al. Chemokine RANTES and IL-1β in mild therapeutic hypothermia-treated patients after out-of-hospital sudden cardiac arrest. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2019;15(1):98-106. doi:10.5114/aic.2019.83653.

APA

Podolec, J., Trąbka-Zawicki, A., Badacz, R., Siedliński, M., Tomala, M.,  & Bartuś, K. et al. (2019). Chemokine RANTES and IL-1β in mild therapeutic hypothermia-treated patients after out-of-hospital sudden cardiac arrest. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, 15(1), 98-106. https://doi.org/10.5114/aic.2019.83653

Chicago

Podolec, Jakub, Aleksander Trąbka-Zawicki, Rafał Badacz, Mateusz Siedliński, Marek Tomala, Krzysztof Bartuś,  and Jacek Legutko et al. 2019. "Chemokine RANTES and IL-1β in mild therapeutic hypothermia-treated patients after out-of-hospital sudden cardiac arrest". Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej 15 (1): 98-106. doi:10.5114/aic.2019.83653.

Harvard

Podolec, J., Trąbka-Zawicki, A., Badacz, R., Siedliński, M., Tomala, M., Bartuś, K., Legutko, J., Przewłocki, T., Żmudka, K.,  and Kabłak-Ziembicka, A. (2019). Chemokine RANTES and IL-1β in mild therapeutic hypothermia-treated patients after out-of-hospital sudden cardiac arrest. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, 15(1), pp.98-106. https://doi.org/10.5114/aic.2019.83653

MLA

Podolec, Jakub et al. "Chemokine RANTES and IL-1β in mild therapeutic hypothermia-treated patients after out-of-hospital sudden cardiac arrest." Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, vol. 15, no. 1, 2019, pp. 98-106. doi:10.5114/aic.2019.83653.

Vancouver

Podolec J, Trąbka-Zawicki A, Badacz R, Siedliński M, Tomala M, Bartuś K et al. Chemokine RANTES and IL-1β in mild therapeutic hypothermia-treated patients after out-of-hospital sudden cardiac arrest. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2019;15(1):98-106. doi:10.5114/aic.2019.83653.

Introduction
CCL5/RANTES and IL-1, which regulate the immune response, may have an impact on survival in patients with acute coronary syndrome (ACS) and sudden cardiac arrest (SCA).

Aim
To evaluate levels of CCL5/RANTES and IL-1 in patients with ACS complicated by SCA, treated with coronary angioplasty (PCI) and mild therapeutic hypothermia (MTH), and these chemokines’ impact on the 30- and 180-day survival.

Material and methods
Thirty-three unconscious patients admitted after SCA with ACS underwent PCI and MTH treatment. CCL5/RANTES and IL-1 were evaluated on admission (T0), at 12–24 h (T1) and at 48–72 h (T2). All-cause mortality was recorded at 30 and 180 days.

Results
We observed a statistically significant decrease in median levels of CCL/RANTES at T0, T1 and T2 (24.69 ng/ml vs. 3.89 ng/ml vs. 2.71 ng/ml; p < 0.001), and significant differences in median levels of IL-1 (0.196 pg/ml vs. 0.171 pg/ml vs. 0.214 pg/ml; p = 0.034). Initial levels of CCL5/RANTES and IL-1 correlated significantly (r = –0.360; p = 0.045). At T2, CCL5/RANTES correlated with the maximum levels of hs-TnT and CK-MB (r = –0.594; p < 0.001 and r = –0.389; p = 0.030), and at T0 with BNP (r = –0.521; p = 0.003). Mortality rate at 30 days and 180 days was 18.2% and 45.5%, respectively. At 30 days, we observed a trend to significance for IL-1 at T0 and T1 (p = 0.078 and p = 0.079), but not for CCL5/RANTES (p = 0.284 and p = 0.351). For 180-day survival curves, only the IL-1 level at T1 was associated with mortality (p = 0.028).

Conclusions
Although CCL5/RANTES levels correlate with cardiac injury and heart failure markers and they decrease during MTH, they failed to predict early and late mortality. In contrast, IL-1 level was associated with 180-day survival.

keywords:

Chemokine RANTES and IL-1β in mild therapeutic hypothermia-treated patients after out-of-hospital sudden cardiac arrest

Jakub Podolec , Aleksander Trąbka-Zawicki , Rafał Badacz , Mateusz Siedliński , Marek Tomala , Krzysztof Bartuś , Jacek Legutko , Tadeusz Przewłocki , Krzysztof Żmudka , Anna Kabłak-Ziembicka

chemokine RANTES, IL-1, mild therapeutic hypothermia, sudden cardiac arrest

Jakub Podolec

,

Aleksander Trąbka-Zawicki

,

Rafał Badacz

,

Mateusz Siedliński

,

Marek Tomala

,

Krzysztof Bartuś

,

Jacek Legutko

,

Tadeusz Przewłocki

,

Krzysztof Żmudka

,

Anna Kabłak-Ziembicka